611 related articles for article (PubMed ID: 29600808)
1. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
[TBL] [Abstract][Full Text] [Related]
2. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
[TBL] [Abstract][Full Text] [Related]
3. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.
Gray SL; Anderson ML; Dublin S; Hanlon JT; Hubbard R; Walker R; Yu O; Crane PK; Larson EB
JAMA Intern Med; 2015 Mar; 175(3):401-7. PubMed ID: 25621434
[TBL] [Abstract][Full Text] [Related]
4. Long-term anticholinergic use and the aging brain.
Cai X; Campbell N; Khan B; Callahan C; Boustani M
Alzheimers Dement; 2013 Jul; 9(4):377-85. PubMed ID: 23183138
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
Pieper NT; Grossi CM; Chan WY; Loke YK; Savva GM; Haroulis C; Steel N; Fox C; Maidment ID; Arthur AJ; Myint PK; Smith TO; Robinson L; Matthews FE; Brayne C; Richardson K
Age Ageing; 2020 Oct; 49(6):939-947. PubMed ID: 32603415
[TBL] [Abstract][Full Text] [Related]
7. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
[TBL] [Abstract][Full Text] [Related]
8. One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults.
Martinez AI; Abner EL; Jicha GA; Rigsby DN; Eckmann LC; Huffmyer MJ; Moga DC
J Manag Care Spec Pharm; 2020 Apr; 26(4):520-528. PubMed ID: 32223601
[TBL] [Abstract][Full Text] [Related]
9. Potentially inappropriate anticholinergic medication use in older adults with dementia.
Kachru N; Carnahan RM; Johnson ML; Aparasu RR
J Am Pharm Assoc (2003); 2015; 55(6):603-612. PubMed ID: 26501745
[TBL] [Abstract][Full Text] [Related]
10. Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors.
Gallagher D; Kiss A; Lanctot KL; Herrmann N
J Clin Psychiatry; 2018 Nov; 80(1):. PubMed ID: 30549490
[TBL] [Abstract][Full Text] [Related]
11. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
[TBL] [Abstract][Full Text] [Related]
13. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
14. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.
Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Wolfe R; Connors MH; Elliott RA
J Alzheimers Dis; 2017; 60(2):349-358. PubMed ID: 28869467
[TBL] [Abstract][Full Text] [Related]
15. Comorbid Mild Cognitive Impairment and Depressive Symptoms Predict Future Dementia in Community Older Adults: A 24-Month Follow-Up Longitudinal Study.
Makizako H; Shimada H; Doi T; Tsutsumimoto K; Hotta R; Nakakubo S; Makino K; Suzuki T
J Alzheimers Dis; 2016 Oct; 54(4):1473-1482. PubMed ID: 27589518
[TBL] [Abstract][Full Text] [Related]
16. Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia.
Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Ilomäki J; Elliott RA
Drugs Aging; 2016 Jan; 33(1):37-44. PubMed ID: 26645294
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.
Swami S; Cohen RA; Kairalla JA; Manini TM
Drugs Aging; 2016 Nov; 33(11):809-818. PubMed ID: 27638818
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression.
Chatterjee S; Bali V; Carnahan RM; Chen H; Johnson ML; Aparasu RR
Res Social Adm Pharm; 2020 Mar; 16(3):329-335. PubMed ID: 31182419
[TBL] [Abstract][Full Text] [Related]
19. Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease.
Sheu JJ; Tsai MT; Erickson SR; Wu CH
Pharmacotherapy; 2019 Aug; 39(8):798-808. PubMed ID: 31251824
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
